Literature DB >> 26602822

Cell penetrating peptide-modified poly(lactic-co-glycolic acid) nanoparticles with enhanced cell internalization.

Jill M Steinbach1, Young-Eun Seo2, W Mark Saltzman2.   

Abstract

The surface modification of nanoparticles (NPs) can enhance the intracellular delivery of drugs, proteins, and genetic agents. Here we studied the effect of different surface ligands, including cell penetrating peptides (CPPs), on the cell binding and internalization of poly(lactic-co-glycolic) (PLGA) NPs. Relative to unmodified NPs, we observed that surface-modified NPs greatly enhanced cell internalization. Using one CPP, MPG (unabbreviated notation), that achieved the highest degree of internalization at both low and high surface modification densities, we evaluated the effect of two different NP surface chemistries on cell internalization. After 2h, avidin-MPG NPs enhanced cellular internalization by 5 to 26-fold relative to DSPE-MPG NP formulations. Yet, despite a 5-fold increase in MPG density on DSPE compared to Avidin NPs, both formulations resulted in similar internalization levels (48 and 64-fold, respectively) after 24h. Regardless of surface modification, all NPs were internalized through an energy-dependent, clathrin-mediated process, and became dispersed throughout the cell. Overall both Avidin- and DSPE-CPP modified NPs significantly increased internalization and offer promising delivery options for applications in which internalization presents challenges to efficacious delivery.
Copyright © 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell penetrating peptides; Drug delivery; Gene delivery; Nanoparticle

Mesh:

Substances:

Year:  2015        PMID: 26602822      PMCID: PMC4695306          DOI: 10.1016/j.actbio.2015.11.029

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  88 in total

1.  Nanomedicine: Downsizing tumour therapeutics.

Authors:  Christopher J Cheng; W Mark Saltzman
Journal:  Nat Nanotechnol       Date:  2012-06-06       Impact factor: 39.213

Review 2.  Delivery of siRNA therapeutics: barriers and carriers.

Authors:  Jie Wang; Ze Lu; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2010-06-11       Impact factor: 4.009

3.  Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells.

Authors:  Kim S Kawamura; Michael Sung; Eleonora Bolewska-Pedyczak; Jean Gariépy
Journal:  Biochemistry       Date:  2006-01-31       Impact factor: 3.162

4.  The effect of particle design on cellular internalization pathways.

Authors:  Stephanie E A Gratton; Patricia A Ropp; Patrick D Pohlhaus; J Christopher Luft; Victoria J Madden; Mary E Napier; Joseph M DeSimone
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

5.  Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates.

Authors:  Jason Park; Thomas Mattessich; Steven M Jay; Atu Agawu; W Mark Saltzman; Tarek M Fahmy
Journal:  J Control Release       Date:  2011-06-24       Impact factor: 9.776

6.  Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.

Authors:  Markus Benfer; Thomas Kissel
Journal:  Eur J Pharm Biopharm       Date:  2011-11-10       Impact factor: 5.571

7.  Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting.

Authors:  Tarek M Fahmy; Robert M Samstein; Casey C Harness; W Mark Saltzman
Journal:  Biomaterials       Date:  2005-04-18       Impact factor: 12.479

8.  Biglycan is internalized via a chlorpromazine-sensitive route.

Authors:  Martin Götte; David Denis Sofeu Feugaing; Hans Kresse
Journal:  Cell Mol Biol Lett       Date:  2004       Impact factor: 5.787

9.  Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.

Authors:  Darryl T Martin; Jill M Steinbach; Jingchun Liu; Shogo Shimizu; Hristos Z Kaimakliotis; Marcia A Wheeler; Adam B Hittelman; W Mark Saltzman; Robert M Weiss
Journal:  Mol Cancer Ther       Date:  2013-11-12       Impact factor: 6.261

10.  Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines.

Authors:  Tiago dos Santos; Juan Varela; Iseult Lynch; Anna Salvati; Kenneth A Dawson
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

View more
  24 in total

1.  Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis.

Authors:  Mohamed Y Mahmoud; Jill M Steinbach-Rankins; Donald R Demuth
Journal:  J Control Release       Date:  2019-01-25       Impact factor: 9.776

2.  Biomimetic Nanoparticle Vaccines for Cancer Therapy.

Authors:  Ashley V Kroll; Yao Jiang; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Adv Biosyst       Date:  2018-11-13

3.  Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.

Authors:  Tiffany N Grooms; Hung R Vuong; Kevin M Tyo; Danial A Malik; Lee B Sims; Carli P Whittington; Kenneth E Palmer; Nobuyuki Matoba; Jill M Steinbach-Rankins
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 4.  The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis.

Authors:  Akshay Jain; Kun Cheng
Journal:  J Control Release       Date:  2016-11-16       Impact factor: 9.776

5.  Efficacy of Surface-Modified PLGA Nanoparticles as a Function of Cervical Cancer Type.

Authors:  Lee B Sims; Keegan C Curry; Sindhu Parupalli; Gwynneth Horner; Hermann B Frieboes; Jill M Steinbach-Rankins
Journal:  Pharm Res       Date:  2019-03-13       Impact factor: 4.200

6.  Poly(amine-co-ester) nanoparticles for effective Nogo-B knockdown in the liver.

Authors:  Jiajia Cui; Alexandra S Piotrowski-Daspit; Junwei Zhang; Mingjie Shao; Laura G Bracaglia; Teruo Utsumi; Young-Eun Seo; Jenna DiRito; Eric Song; Christine Wu; Asuka Inada; Gregory T Tietjen; Jordan S Pober; Yasuko Iwakiri; W Mark Saltzman
Journal:  J Control Release       Date:  2019-05-01       Impact factor: 9.776

Review 7.  Peptide-Modified Biopolymers for Biomedical Applications.

Authors:  Jessica Hersh; David Broyles; José Manuel Condor Capcha; Emre Dikici; Lina A Shehadeh; Sylvia Daunert; Sapna Deo
Journal:  ACS Appl Bio Mater       Date:  2020-12-24

8.  Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer.

Authors:  Lee B Sims; Louis T Curtis; Hermann B Frieboes; Jill M Steinbach-Rankins
Journal:  J Nanobiotechnology       Date:  2016-04-22       Impact factor: 10.435

Review 9.  Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.

Authors:  Elias Quijano; Raman Bahal; Adele Ricciardi; W Mark Saltzman; Peter M Glazer
Journal:  Yale J Biol Med       Date:  2017-12-19

10.  In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection.

Authors:  Farnaz Minooei; Joel R Fried; Joshua L Fuqua; Kenneth E Palmer; Jill M Steinbach-Rankins
Journal:  Int J Nanomedicine       Date:  2021-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.